A pharmacist's touch: could structured medication reviews boost HIV treatment success?

NCT ID NCT07750834

Completed Disease control Sponsor: Universiti Sains Malaysia Source: ClinicalTrials.gov ↗

First seen Aug 06, 2026 · Last updated Aug 11, 2026 · Updated 3 times

Summary

This trial tests whether a structured, pharmacist-led medication management program can help HIV patients at high risk of drug-related problems take their medications more consistently. Participants are randomly assigned to usual care, a basic program, or an enhanced program with extra support like pill organizers and home visits. The study tracks adherence, viral load, and quality of life over 24 months to see if the extra support makes a meaningful difference.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Pharmacist-led Medication Therapy Management (MTM) program
What this could lead to: If effective, this program could become a standard approach to help HIV patients stick to their medications, potentially improving viral suppression and quality of life in resource-limited settings.
What could go wrong: The trial is early and the outcome depends on patient engagement and healthcare infrastructure. Results may not generalize beyond this specific setting, and the added pharmacist time may not prove cost-effective.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS Drug-Related Side Effects and Adverse Reactions HIV infectious disease Treatment Adherence and Compliance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV INFECTIONS

Contacts and locations

Locations

Omdurman teaching Hospital

Khartoum, Omdurman, 1111, Sudan

More trials for these conditions

Other studies related to the condition(s) this trial covers.